# Study of Home Full Blood Count (FBC) Telemonitoring Device for Chemotherapy Patient

> **NCT01436669** · NA · COMPLETED · sponsor: **Philips Healthcare** · enrollment: 20 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DEVICE:** Home Telemonitoring System (The Zodiac, Philips Health care)

## Key facts

- **NCT ID:** NCT01436669
- **Lead sponsor:** Philips Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-03-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01436669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01436669, "Study of Home Full Blood Count (FBC) Telemonitoring Device for Chemotherapy Patient". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01436669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*